薛宜家 林志堅 / Taipei Report ; Published：2021-09-23 12:56 Updated : 2021-09-23 14:43
- [NEWS] MoneyDJ理財網 : Pharmasaga to List on Emerging Stock Market on 27th; Type 2 Diabetes Phase Ib Clinical Trial Aims for Completion Next Year
- [NEWS] 富聯網 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] 富聯網 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 旺得富 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 旺得富 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 時報資訊 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 財訊快報 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] GENE ONLINE: Pharmasaga Wins Bronze Medal for Innovative Technology at the 2025 Taipei Biotech Awards
- [NEWS] NTTC: NSTC Leads 8 Biomedical Startups into BIO USA 2025; Pharmasaga Advances to Global Competition Finals Again
- [NEWS] 環球生技 : Pharmasaga's Innovative Diabetes Drug PS1 Demonstrates Curative Potential, Initiates Taiwan-US Clinical Trials
- [NEWS] 經濟部 : BIO 2025 North America Biotech Exhibition Opens; Taiwan Pavilion Showcases Taiwan's Innovative Biomedical Technology
- [NEWS] GENE ONLINE : Taiwan Participates in BIO 2025 North America Biotech Exhibition with Dual Focus on All-Age Healthcare Layout and International Connections
- [NEWS] 環球生技 : NSTC Leads 8 Biomedical Startups to BIO 2025; Pharmasaga Reaches Finals Again
- [NEWS] Yahoo新聞 : Taiwan Pavilion Showcases Taiwan's Biomedical Technology at North America Biotech Exhibition
- [NEWS] Yahoo股市 : BIO 2025 North America Biotech Exhibition: Taiwan Pavilion Highlights 5 Biomedical Innovations
- [NEWS] Ltvnews : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
- [NEWS] Biomedical Technology Development
- [NEWS] 工商時報 : (Industry) Taiwanese Companies Attend BIO 2025 North America Biotech Exhibition; Ministry of Economic Affairs Reveals 5 Highlights
- [NEWS] CENS : NSTC Leads 8 Biomedical Startups to BIO Exhibition in the US, Aiming for International Licensing and Investment
- [NEWS] GOTHE : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
2021/9/23 12:51 (Updated 9/23 13:21)
Sep 23
2021.9 CTS News: Academia Sinica Discovers Reversal Mechanism, Diabetes is Poised to Be Curable!
A team from Academia Sinica's Agricultural Biotechnology Center has discovered a gene that, if overexpressed, leads to the failure of pancreatic beta-cells. Consequently, late-stage diabetic patients must rely solely on insulin injections to slow the progression of the disease. However, now that the mechanism of this gene is understood, they have...
The current situation where diabetes is considered incurable is set to be reversed! A team led by Dr. Wen-Ching Yang, a research fellow at the Agricultural Biotechnology Research Center of Academia Sinica, discovered through mouse experiments that Pdia4 (Protein Disulfide Isomerase) is responsible for regulating pancreatic beta-cells. By using the...
Dr. Wen-Ching Yang's research team at Academia Sinica discovered that Pdia4 is mainly expressed in pancreatic beta-cells, and over-nutrition increases the expression of Pdia4 in human and mouse beta-cells. In diabetic mice, the Pdia4 gene knockout was found to alleviate diabetes and islet failure in the disease model, simultaneously lowering...
Diabetes Future Research and Application Symposium
In April 2021, Pharmasaga presented the latest research results of PS-001 at the Demo Day event hosted by Academia Sinica's Center for Translational Research. The presentation received an enthusiastic response from many investors and professionals in attendance.
The Future Tech Exhibition 2020 (FUTEX 2020) was held from September 24th to September 26th, 2020, with over 600 startup teams participating. Our first-in-class diabetes drug, PS1, was highly honored receiving the prestigious Future Tech Award, and earning recognition from numerous domestic experts. We firmly believe that in the near future, PS1...